| Literature DB >> 35681482 |
Marion Bendayan1,2, Liliana Caceres1, Emine Saïs1,2, Nelly Swierkowski-Blanchard3, Laura Alter1,2, Amélie Bonnet-Garnier2, Florence Boitrelle1,2.
Abstract
BACKGROUND: Human sperm chromatin condensation is a sum of epigenetic events that allows for the near-complete replacement of histones with protamines. Under high-magnification microscopy, nuclear vacuoles have been described as thumbprints with poor chromatin condensation. The objective of this study is to examine whether vacuolated spermatozoa carry specific epigenetic marks, which may influence embryo development.Entities:
Keywords: H3; H3K27me3; H3K4me3; chromatin; embryo; epigenetic mark; high magnification microscopy; histone; human sperm; sperm vacuoles; vacuole
Mesh:
Substances:
Year: 2022 PMID: 35681482 PMCID: PMC9180039 DOI: 10.3390/cells11111788
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Main sperm characteristics of the included patients.
| Patients | Age | Etiology | Abstinence Time | Semen Volume (mL) | Sperm Concentration (106/mL) | Total Sperm Count | Sperm Vitality (%) | Sperm Total Motility (%) | Sperm Progressive Motility (%) | Sperm Typical Forms 1 (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 34 | Exclusively female | 2 | 3.2 | 34.3 | 109.8 | 78 | 60 | 40 | 25 |
| 2 | 42 | Idiopathic | 2 | 4.3 | 21.6 | 92.9 | 83 | 45 | 35 | 31 |
| 3 | 32 | Exclusively female | 3 | 2.6 | 42.7 | 111.0 | 65 | 50 | 40 | 24 |
| 4 | 38 | Idiopathic | 2 | 2.8 | 57.2 | 160.2 | 71 | 60 | 45 | 36 |
| 5 | 29 | Idiopathic | 4 | 5.9 | 19.9 | 117.4 | 81 | 60 | 50 | 39 |
| 6 | 26 | Exclusively female | 3 | 3.3 | 33.2 | 109.6 | 82 | 50 | 40 | 33 |
| 7 | 44 | Idiopathic | 5 | 4.1 | 48.3 | 198.0 | 76 | 60 | 45 | 27 |
| 8 | 48 | Idiopathic | 4 | 2.3 | 29.0 | 66.7 | 79 | 60 | 55 | 29 |
| 9 | 31 | Idiopathic | 3 | 2.6 | 28.3 | 73.6 | 64 | 45 | 35 | 32 |
| 10 | 32 | Exclusively female | 4 | 2.7 | 46.1 | 124.5 | 69 | 50 | 35 | 25 |
| 11 | 28 | Exclusively male | 2 | 6.4 | 2.2 | 14.1 | 64 | 30 | 20 | 13 |
| 12 | 34 | Combined male and female | 5 | 1.9 | 8.6 | 16.3 | 76 | 50 | 30 | 21 |
| 13 | 26 | Exclusively male | 2 | 5.8 | 1.9 | 11.0 | 45 | 20 | 15 | 5 |
| 14 | 47 | Exclusively male | 2 | 3.1 | 5.7 | 17.7 | 77 | 40 | 30 | 12 |
| 15 | 39 | Combined male and female | 3 | 4.2 | 6.3 | 26.5 | 71 | 40 | 30 | 17 |
| 16 | 44 | Combined male and female | 3 | 1.7 | 7.2 | 12.2 | 48 | 20 | 10 | 2 |
| 17 | 32 | Combined male and female | 2 | 2.5 | 10.3 | 25.8 | 52 | 30 | 15 | 13 |
| 18 | 38 | Exclusively male | 4 | 2.1 | 11.9 | 25.0 | 56 | 30 | 20 | 18 |
| 19 | 27 | Exclusively male | 2 | 3.0 | 9.4 | 28.2 | 82 | 50 | 30 | 20 |
| 20 | 33 | Combined male and female | 4 | 3.2 | 10.1 | 32.3 | 64 | 40 | 30 | 8 |
1 The classification used for the measurement of typical forms is the modified David classification [47].
Figure 1Human spermatozoa observed at high magnification with differential interference contrast (DIC) microscopy (IMSI-like). (A) A grade I morphometrically normal spermatozoon with no vacuole. (B) A grade III morphometrically normal spermatozoon with one large vacuole.
Figure 2Summary diagram of the experimental workflow.
Nuclear proteins and epigenetics marks of histones described in human spermatozoa (n = 137).
| Nuclear Proteins (n = 7) | |
|---|---|
| Protamine (2) | protamine 1, |
| Core histones (5) | H1, H2A, H2B, |
| Protamine epigenetic marks (n = 3) | |
| P1 (3) | ph1, ph27ac1, ph3 |
| P2 (0) | |
| Histone variants (n = 23) | |
| H1 (3) | H1.4, H1.t, H1.t2 |
| H2A (11) | H2A.1a, H2A.2b, H2A.2c, H2A.3, H2A.J, H2A.V, H2A.X, H2A-bbd 2/3, H2A.Z, macroH2A.1, macroH2A.2 |
| H2B (6) | tH2B., H2B.1b, H2B.1c/e/f, H2B.1d, H2B.1 l, H2B.2f |
| H3 (3) | H3, H3.3, H3.1t |
| H4 (0) | |
| Histones PTMs (n = 104) | |
| H1 (4) | K43ac, R50me1, K62me1, K63ac |
| H1t (13) | K112me1, K113ac, K122ac, K124me1, K170ac, K173me1, K183ac, K183me3, R185me1, S180ph, S187ph, K188me1, K190ac |
| H2A (3) | K5ac, R11me2, R29me1 |
| H2AV/Z (21) | K4ac, K4me2/3, K7ac, K7cr, K7me1/2/3, S9ph, K11cr, K11me1/2/3, K13cr, K13me2/3, K15ac, R19me1, K27ac, K37cr, K37me1 |
| H2B (2) | K16me1, K20me3 |
| tH2B (15) | K6ac, T9ph, K12ac, K12me1/3, K13me1/3, K16me1/3, K17me1, K28ac, K29ac, R30me2, K86ac, R87me1 |
| H3 (31) | T3ph, |
| H4 (15) | S1ph, R3me1, K5ac, K8ac, K12ac, K16ac, K9ac, |
Bolded epigenetic marks correspond to those studied in this manuscript (n = 10). Abbreviations: PTMs = post-translational histone modifications. Modifications: me = methylation, ph = phosphorylation, ac = acetylation, cr = crotonylation, Ox = oxidation. Residues: K = lysine, S = serine, R = arginine, T = threonine, M = methionine.
Pairing of epigenetic marks and primary antibodies used.
| Pairing | Rabbit Antibody | Mouse Antibody |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 | ||
| 5 |
For each pair of epigenetic marks targeted, rabbit and mouse antibodies were used. Antibodies marked in red are antibodies coupled to Cyanin 3 (Cy3) and antibodies marked in green are antibodies coupled to Fluorescein isothiocyanate (FITC).
Figure 3Spermatozoa observed under a two-dimensional fluorescence microscope. A spermatozoon observed with (A) DAPI labelling (blue), (B) H3-Cy3 positive labelling (red), and (C) DAPI/H3-Cy3 merge. Another spermatozoon observed with (D) DAPI labelling, (E) H3-Cy3 negative labelling, and (F) DAPI/H3-Cy3 merge. A spermatozoon observed with (G) DAPI labelling, (H) P2-FITC positive labelling, and (I) DAPI/P2-FITC merge. Another spermatozoon observed with (J) DAPI labelling, (K) P2-FITC negative labelling, and (L) DAPI/P2-FITC merge. H3: histone 3; Cy3: cyanin3; P2: protamine 2; FITC: fluorescein isothiocyanate; DAPI: 4′,6-diamino-2-phenylindole.
Mean and median values of H3, P2, and PTMs observed in the 20 patients according to sperm morphology.
| Non-Vacuolated Sperm (%) | Vacuolated Sperm (%) | ||||||
|---|---|---|---|---|---|---|---|
| Nuclear Proteins and PTMs | Mean ± SEM | Median | Q3–Q1 | Mean ± SEM | Median | Q3–Q1 | |
|
| 74.8 ± 4.8 | 80.9 | 62.5–90 | 88.1 ± 2.7 | 90 | 83.7–95 |
|
|
| 82.1 ± 4.4 | 88.8 | 67.8–100 | 50.2 ± 6.2 | 35 | 28.8–76.3 |
|
| H3K4me1 | 5.4 ± 0.8 | 5.0 | 3.1–8 | 6.2 ± 0.8 | 8 | 5–8.5 | 0.325 |
| H3K4me2 | 6.4 ± 1.0 | 5.0 | 5.0–10 | 6.3 ± 0.9 | 6.5 | 5– 8.3 | 0.71 |
|
| 49.1 ± 7.4 | 46.3 | 13.8–76.7 | 78.5 ± 5.2 | 88.2 | 73.3–95 |
|
| H3K9me1 | 31.1 ± 6.3 | 25 | 10–43.5 | 42.3 ± 4.8 | 35 | 33.3–68.2 | 0.165 |
| H3K9me2 | 22.6 ± 6.5 | 7.5 | 0.0–32.5 | 15.4 ± 4.7 | 73 | 0.0–25.9 | 0.13 |
| H3K9me3 | 61.8 ± 6.9 | 69.1 | 26.7–85.7 | 62.2 ± 4.9 | 65 | 47.7–71.2 | 0.911 |
|
| 73.6 ± 5.1 | 85.7 | 58.8–90 | 63.9 ± 6.3 | 79.2 | 42.5–85.9 |
|
| H4K20me2 | 18.7 ± 2.6 | 17.4 | 9.9–27.3 | 24.7 ± 4.5 | 17.4 | 9.1–31 | 0.121 |
Values are represented as mean ± standard error to mean (SEM), median, interquartile ranges (Q1–Q3), and estimators (Wilcoxon statistic and p-value). Significance is considered when p ≤ 0.05 and is indicated by an asterisk *. H3: histone 3, P2: protamine 2, PTMs: post-translational histone modifications.
Figure 4Percentage of non-vacuolated spermatozoa (blue box) and vacuolated spermatozoa (orange box) positively targeted for each of the ten epigenetic marks evaluated. Boxes represent data included in third and first interquartile range (Q3–Q1), horizontal bars represent median, and black squares represent mean. Whiskers represent upper (95%) and lower (5%) confidence intervals. Asterisks indicate significative differences among vacuolated and non-vacuolated spermatozoa (p < 0.05).
Figure 5Morphometrically normal spermatozoa with one large vacuole observed with a two-dimensional fluorescence microscope. A vacuolated spermatozoon observed with (A) DAPI labelling (blue) and (B) histone 3 labelling (red, anti-H3). The vacuole is circled in dotted line. H3 labelling is diffuse and occupies the entire sperm head ((C) merged DAPI/H3-Cy3). Another vacuolated spermatozoon observed with (D) DAPI labelling and (E) H3K4me3 labelling (anti-H3K4me3). The vacuole is circled in dotted line. H3K4me3 labelling is prevalent in certain areas corresponding to DAPI-free zones ((F) merged DAPI/H3K4me3-Cy3). DAPI: 4′,6-diamino-2-phenylindole, Cy3: cyanin3.
Figure 6Morphometrically normal spermatozoa without vacuole observed with a two-dimensional fluorescence microscope. A morphometrically normal without vacuole spermatozoon observed with (A) DAPI labelling (blue), (B) histone 3 labelling (red, anti-H3), and (C) merged DAPI/H3-Cy3. Another morphometrically normal without vacuole spermatozoon observed with (D) DAPI labelling, (E) H3K4me3 labelling (anti-H3K4me3), and (F) merged DAPI/H3K4me3-Cy3. DAPI: 4′,6-diamino-2-phenylindole, Cy3: cyanin3.
Figure 7Three-dimensional reconstruction by optical sectional microscopy and deconvolution of a morphometrically normal spermatozoon without vacuole, tagged for H3K4me3. (A) Schematic of the upper plane (a), frontal plane (b), and a cross-section (c) of the spermatozoon. (B) The spermatozoon visualized with differential interference contrast (DIC). Three-dimensional reconstructed images of the spermatozoon with (C) DAPI labelling, (D) H3K4me3 labelling, and (E–G) DAPI/H3K4me3 labelling. DAPI: 4′,6-diamino-2-phenylindole.
Figure 8Three-dimensional reconstruction by optical sectional microscopy and deconvolution of a morphometrically normal spermatozoon with one vacuole (occupying more than 15% of head surface), tagged for H3K4me3. (A) Schematic of the upper plane (a), frontal plane (b), and a cross-section (c) of the spermatozoon. (B) The spermatozoon visualized with differential interference contrast (DIC). Three-dimensional reconstructed images of the spermatozoon with (C) DAPI labelling, (D) H3K4me3 labelling, and (E–G) DAPI/H3K4me3 labelling. DAPI: 4′,6-diamino-2-phenylindole.